Clinical trial
PHIL dAVF: Study of PHIL® Embolic System In The Treatment of Intracranial Dural Arteriovenous Fistulas
NCT03467542 is registered in ClinicalTrials.gov with Microvention-Terumo, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PHIL dAVF: Study of PHIL® Embolic System In The Treatment of Intracranial Dural Arteriovenous Fistulas
- Lead sponsor
- Microvention-Terumo, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 24, 2018
- Completion date
- December 12, 2022
- Enrollment
- 64 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arteriovenous dural fistula